Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082134
Status:
COMPLETED
Last Update Posted:
2015-03-05
First Post:
2004-04-29
Brief Title:
Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
ILX651-241
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None